Updated July 2026 · 9 min read
Part of the ICU Pharmacology Hub — browse every related guide in one place.
These two drugs hang side by side on countless septic-shock patients, but they could hardly be more different: one is a titratable catecholamine, the other a fixed-dose hormone; one works through adrenergic receptors, the other does not. Knowing exactly how they differ is what lets you read a pressor order like a sentence instead of a list.
Everything else follows from this. Norepinephrine acts on adrenergic receptors — mostly alpha-1 (vasoconstriction) with some beta-1 (a little more squeeze and rate). Vasopressin acts on V1 receptors on vascular smooth muscle, an entirely separate signaling system. That single fact explains why they complement each other so well: when prolonged, acidotic shock downregulates and desensitizes the adrenergic receptors and norepinephrine starts losing its grip, vasopressin can keep constricting through a pathway the acidosis and desensitization have not touched.
| Feature | Norepinephrine | Vasopressin |
|---|---|---|
| Drug class | Catecholamine | Hormone (ADH analog) |
| Receptor | Alpha-1 > beta-1 | V1 (vascular) |
| Line in septic shock | First-line | Second-line add-on |
| Dosing | Titrated to MAP (e.g., mcg/kg/min) | Fixed (commonly 0.03 units/min) |
| Inotropy / chronotropy | Modest beta-1 lift | None (pure vasoconstrictor) |
| Effect in acidosis | Can lose potency | Relatively preserved |
| Main risk profile | Arrhythmias, extravasation necrosis | Digital / mesenteric ischemia |
| Reversal for extravasation | Phentolamine | Treat ischemia; central line preferred |
In practice the sequence looks like this. The patient in septic shock is fluid-resuscitated, and if the MAP still will not hold at 65, norepinephrine goes up first and is titrated. When the norepinephrine dose keeps climbing — a rising requirement is itself a warning sign that the shock is winning — the team adds vasopressin at its fixed dose rather than pushing norepinephrine ever higher. The vasopressin both nudges the pressure up and lets you hold or lower the catecholamine, reducing arrhythmia risk and adrenergic burden. From there, the ladder continues: reassess volume, consider stress-dose steroids, add an inotrope if the heart is the problem, and reconsider whether the source is truly controlled. The full sequence is laid out in the refractory septic shock vasopressor ladder.
Norepinephrine gives only a modest inotropic lift, so it is not the answer when the real problem is a failing pump — that patient may need an inotrope or a different strategy. Vasopressin gives no inotropy or chronotropy at all; it is pure vasoconstriction, so it does nothing for a heart that cannot generate output and can actually worsen perfusion if leaned on too hard. Neither drug fixes uncontrolled source, unaddressed hypovolemia, or untreated adrenal insufficiency. Reading the pressors correctly also means recognizing when the ladder is telling you to look somewhere other than the infusion pump — the lactate trend is your honest scorecard.
Norepinephrine and vasopressin are the classic septic-shock pairing, but they are not the only pressors you will see. Epinephrine and phenylephrine differ again in their receptor balance and best use cases — that comparison is covered in the norepinephrine vs. epinephrine vs. phenylephrine guide. The organizing principle across all of them is the same: match the drug's receptor profile to the physiologic problem in front of you.
On the CRNA path, you will reach for norepinephrine constantly to manage anesthesia-induced hypotension, and for vasopressin specifically when a patient is vasoplegic — profoundly vasodilated and refractory to catecholamines after bypass, in anaphylaxis, or on chronic ACE inhibitors/ARBs. Knowing that these two drugs pull different levers is exactly what lets you rescue an OR pressure that will not respond to "more of the same." The bedside comparison you learn now is the intraoperative decision you will make later.
Norepinephrine and vasopressin are teammates, not rivals: a titratable first-line catecholamine and a fixed-dose second-line hormone that work through different receptors. Titrate the norepinephrine to the MAP, add vasopressin to raise the pressure and spare the catecholamine, watch the periphery and gut for the ischemia vasopressin can cause, and wean per protocol.
This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify every dose independently.
Get the ICU Notebook
Free investing strategies built for nurses. One email per week, no fluff.
Yes, send it freeNo spam. Unsubscribe any time.